Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2Withdrawn 1Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Motor Activity 3Smoking 1Prostatic Neoplasms 1Obesity 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Esophageal Neoplasms 1Death 1Colorectal Cancer Prevention 1Cardiovascular Diseases 1Breast Neoplasms 1

Interventions

enzalutamide 33Abiraterone Acetate 28apalutamide 25Radiotherapy 25Prednisone 25Magnetic Resonance Spectroscopy 25Androgen Antagonists 24Leuprolide 21Radiosurgery 19darolutamide 18Docetaxel 17acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 15Gonadotropin-Releasing Hormone 14gallium 68 PSMA-11 12Specimen Handling 12Goserelin 12pembrolizumab 11Radiotherapy, Intensity-Modulated 11Radiation 11bicalutamide 10abiraterone 10Pluvicto 10Carboplatin 9Brachytherapy 92-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 9relugolix 8luprolide acetate gel depot 8Standard of Care 8Nivolumab 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Prostatic Neoplasms × Diet × Clear all
NCT03999151 2025-05-29

Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)

University of California, San Francisco

Phase NA Active not recruiting
204 enrolled
Genitourinary

Motor Activity, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡